<?xml version="1.0" encoding="UTF-8" standalone="no" ?>
<rss version="2.0">
  <channel>
    <title>Verbraak, A.F.M.</title>
    <link>http://repub.eur.nl/res/aut/1162/</link>
    <description>List of Publications</description>
    <language>en</language>
    <image>
      <url>http://repub.eur.nl/static-eur/img/logo.png</url>
      <title>RePub, Erasmus University Rotterdam</title>
      <link>http://repub.eur.nl</link>
    </image>
    <item>
      <title>Influence of lung parenchymal destruction on the different indexes of the methacholine dose-response curve in COPD patients (Article)</title>
      <link>http://repub.eur.nl/res/pub/9317/</link>
      <pubDate>2000-01-01T00:00:00Z</pubDate>
      <description>STUDY OBJECTIVES: The interpretation of nonspecific bronchial provocation
          dose-response curves in COPD is still a matter of debate. Bronchial
          hyperresponsiveness (BHR) in patients with COPD could be influenced by the
          destruction of the parenchyma and the augmented mechanical behavior of the
          lung. Therefore, we studied the interrelationships between indexes of BHR,
          on the one hand, and markers of lung parenchymal destruction, on the
          other. PATIENTS AND METHODS: COPD patients were selected by clinical
          symptoms, evidence of chronic, nonreversible airways obstruction, and BHR,
          which was defined as a provocative dose of a substance (histamine) causing
          a 20% fall in FEV(1) (PC(20)) of &lt;/= 8 mg/mL. BHR was subsequently studied
          by methacholine dose-response curves to which a sigmoid model was fitted
          for the estimation of plateau values and reactivity. Model fits of
          quasi-static lung pressure-volume (PV) curves yielded static lung
          compliance (Cstat), the exponential factor (KE) and elastic recoil at 90%
          of total lung capacity (P90TLC). Carbon monoxide (CO) transfer was
          measured with the standard single-breath method. RESULTS: Twenty-four
          patients were included in the study, and reliable PV data could be
          obtained from 19. The following mean values ( +/- SD) were taken: FEV(1),
          65 +/- 12% of predicted; reversibility, 5.6 +/- 3.1% of predicted; the
          PC(20) for methacholine, 4.3 +/- 5.2 mg/mL; reactivity, 11.0 +/- 5.6%
          FEV(1)/doubling dose; plateau, 48.8 +/- 17.4% FEV(1); transfer factor,
          76.7 +/- 17.9% of predicted; transfer coefficient for carbon monoxide
          (KCO), 85.9 +/- 22.6% of predicted; Cstat, 4.28 +/- 2.8 kPa; shape factor
          (KE), 1.9 +/- 1.5 kPa; and P90TLC, 1.1 +/- 0.8 kPa. We confirmed earlier
          reported relationships between Cstat, on the one hand, and KE (p &lt;
          0.0001), P90TLC (p = 0.0012), and KCO percent predicted (p = 0.006), on
          the other hand. The indexes of the methacholine provocation test were not
          related to any parameter of lung elasticity and CO transfer. CONCLUSION:
          BHR in COPD patients who smoke most probably is determined by airways
          pathology rather than by the augmented mechanical behavior caused by lung
          parenchymal destruction.</description>
    </item> <item>
      <title>Modelling and Data Processing in Pulmonary Function (Doctoral Thesis)</title>
      <link>http://repub.eur.nl/res/pub/17650/</link>
      <pubDate>1998-01-07T00:00:00Z</pubDate>
      <description></description>
    </item> <item>
      <title>Dead space and slope indices from the expiratory carbon dioxide tension-volume curve (Article)</title>
      <link>http://repub.eur.nl/res/pub/8713/</link>
      <pubDate>1997-08-01T00:00:00Z</pubDate>
      <description>The slope of phase 3 and three noninvasively determined dead space
          estimates derived from the expiratory carbon dioxide tension (PCO2) versus
          volume curve, including the Bohr dead space (VD,Bohr), the Fowler dead
          space (VD,Fowler) and pre-interface expirate (PIE), were investigated in
          28 healthy control subjects, 12 asthma and 29 emphysema patients (20
          severely obstructed and nine moderately obstructed) with the aim to
          establish diagnostic value. Because breath volume and frequency are
          closely related to CO2 elimination, the recording procedures included
          varying breath volumes in all subjects during self-chosen/natural
          breathing frequency, and fixed frequencies of 10, 15 and 20 breaths x
          min(-1) with varying breath volumes only in the healthy controls. From the
          relationships of the variables with tidal volume (VT), the values at 1 L
          were estimated to compare the groups. The slopes of phase 3 and VD,Bohr at
          1 L VT showed the most significant difference between controls and
          patients with asthma or emphysema, compared to the other two dead space
          estimates, and were related to the degree of airways obstruction.
          Discrimination between no-emphysema (asthma and controls) and emphysema
          patients was possible on the basis of a plot of intercept and slope of the
          relationship between VD,Bohr and VT. A combination of both the slope of
          phase 3 and VD,Bohr of a breath of 1 L was equally discriminating. The
          influence of fixed frequencies in the controls did not change the results.
          The conclusion is that Bohr dead space in relation to tidal volume seems
          to have diagnostic properties separating patients with asthma from
          patients with emphysema with the same degree of airways obstruction.
          Equally discriminating was a combination of both phase 3 and Bohr dead
          space of a breath of 1 L. The different pathophysiological mechanisms in
          asthma and emphysema leading to airways obstruction are probably
          responsible for these results.</description>
    </item> <item>
      <title>Does phase 2 of the expiratory PCO2 versus volume curve have diagnostic value in emphysema patients? (Article)</title>
      <link>http://repub.eur.nl/res/pub/8558/</link>
      <pubDate>1995-01-01T00:00:00Z</pubDate>
      <description>It has been postulated that serial inhomogeneity of ventilation in the
      peripheral airways in emphysema is represented by the shape of expiratory
      carbon dioxide tension versus volume curve. We examined the diagnostic
      value of this test in patients with various degrees of emphysema. The
      volumes between 25-50% (V25-50) and 25-75% (V25-75) of the expiratory
      carbon dioxide tension versus volume curve were determined in 29
      emphysematous patients (20 severely obstructed and 9 moderately
      obstructed), 12 asthma patients in exacerbation of symptoms, and 28
      healthy controls. Discriminant analysis was used to examine whether these
      diagnostic groups could be separated. With regard to phase 2 of the
      expiratory CO2 versus volume curve (mixture of anatomic deadspace and
      alveolar air), a plot of intercept versus slope of the relationships of
      (V25-50) and (V25-75) versus inspiratory volume (VI) from functional
      residual capacity (FRC), obtained during natural breathing frequency,
      proved to be most discriminating in the separation between healthy
      controls and severely obstructed emphysema patients. Separating healthy
      controls and severely obstructed emphysema patients on the basis of the
      discriminant line for V25-50, 9 of the 12 asthma patients in exacerbation
      were classified as normal, and only 5 of the 9 moderately obstructed
      emphysema patients as emphysematous. For V25-75 involvement of phase 3 of
      the curve (alveolar plateau) in asthma patients in exacerbation caused a
      marked overlap with the severely obstructed emphysema patients. In the
      healthy controls, a fixed breathing frequency of 20 breaths.min-1 led to
      an increase of both volumes.(ABSTRACT TRUNCATED AT 250 WORDS)</description>
    </item> <item>
      <title>Pressure-volume analysis of the lung with an exponential and linear-exponential model in asthma and COPD. Dutch CNSLD Study Group (Article)</title>
      <link>http://repub.eur.nl/res/pub/8603/</link>
      <pubDate>1995-01-01T00:00:00Z</pubDate>
      <description>The prevalence of abnormalities in lung elasticity in patients with asthma
          or chronic obstructive pulmonary disease (COPD) is still unclear. This
          might be due to uncertainties concerning the method of analysis of
          quasistatic deflation lung pressure-volume curves. Pressure-volume curves
          were obtained in 99 patients with moderately severe asthma or COPD. These
          patients were a subgroup from a Dutch multicentre trial; the entire group
          was selected on the basis of a moderately lowered % predicted forced
          expiratory volume in one second (FEV1), and a provocative concentration of
          histamine producing a 20% decrease in FEV1 (PC20) &lt; 8 mg.mL-1 obtained
          with the 2 min tidal breathing technique. The curves were fitted with an
          exponential (E) model and an exponential model which took the linear
          appearance in the mid vital capacity range into account
          (linear-exponential (LE)). The linear-exponential model showed a markedly
          better fit ability, yielding additional parameters, such as the compliance
          at functional residual capacity (FRC) level as slope of the linear part
          (b), and the volume at which the linear part changed into the exponential
          part of the curve (transition volume (Vtr)). Vtr (mean value Vtr/total
          lung capacity (TLC) = 0.79 (SD 0.07)) showed a close positive linear
          correlation with obstruction and hyperinflation variables, which might be
          due to airway closure, already starting at elevated lung volumes. The
          exponential shape factor K was closely correlated with b and mean values
          (K = 1.32 (SD 0.05) kPa-1; b = 2.96 (SD 1.16) L,kPa-1) and the
          relationship with age was comparable with data reported in healthy
          individuals. The shape factor of the linear-exponential fit showed no
          correlation with any elasticity related variable. Neither the elastic
          recoil at 90% TLC, as obtained from the linear-exponential fit, nor its
          relationship with age were significantly different from healthy
          individuals. We conclude that, for a more accurate description of the lung
          pressure-volume curve, a linear-exponential fit is preferable to an
          exponential model. However, the physiological relevance of the shape
          parameter (KLE) is still unclear. These results indicate that patients
          with moderately severe asthma or COPD had, on average, no appreciable loss
          of elastic lung recoil as compared with healthy individuals.</description>
    </item>
  </channel>
</rss>